ADO-TRASTUZUMAB EMTANSINE KADCYLA : Cost/Price, Dosage/Doses, Uses, Side Effects, Warnings etc. information...read more
|Quantity / Pack||Price / Pack||Get Discount||Net Price|
|1 Vial||3078||308||US$ 2770||ADD TO CART|
|2 Vial||6156||739||US$ 5417||ADD TO CART|
|4 Vial||12311||1600||US$ 10711||ADD TO CART|
Generic ADO-TRASTUZUMAB EMTANSINE / Brand KADCYLA 100 mg Injection Vial is used to treat Breast Cancer....read more
|Quantity / Pack||Price / Pack||Get Discount||Net Price|
|1 Vial||4667||467||US$ 4200||ADD TO CART|
|2 Vial||9333||1120||US$ 8213||ADD TO CART|
|4 Vial||18667||2427||US$ 16240||ADD TO CART|
Generic ADO-TRASTUZUMAB EMTANSINE / Brand KADCYLA 160 mg Injection Vial is used to treat Breast Cancer....read more
Global Express Shipping :
at Actual Costs only
Superfast Delivery :
3-7 working days*
Rx Prescription Required
for Human Use
Ut Undertaking Required
for R&D Scholarly Studies
* All brand-names and trademarks are the property of their respective owners. Images are for reference only.
See Brand/Sales Disclaimer: The Brand names...
** Products will be shipped from a Licensed Pharmacy of Belgium, Canada, Germany, India, Ireland, Italy, Mexico, Singapore, South Africa, Spain, Turkey etc.
Marketing & Advertising Disclosure: 911GlobalMeds.com is an online...
Marketing & Advertising Disclosure: 911GlobalMeds.com is an online pharmaceuticals marketplace serving as a platform for global buyers and legal registered pharmacy sellers from different countries to connect with each other. All our pharmacy seller clients are minutely vetted to ensure that they are a Legal Registered Pharmacy having all the legally required registrations and licenses issued by the relevant departments of their jurisdictional Government Authorities. All the medicine products on our site are posted on behalf of the Legal Seller Pharmacy, are openly available at any pharmacy in the Country of Export, do not contain any Narcotic drug or ingredients and do not require any additional export permission from any Government Authority from the country of origin. The site adheres to the Right to Internet Access, also known as the Right to Broadband or Freedom to Connect, that all people globally must be able to access the Internet in order to exercise and enjoy their rights to freedom of expression and opinion and other fundamental human rights, that states have a responsibility to ensure that Internet access is broadly available, and that states may not unreasonably restrict an individual's access to the Internet. In compliance to US Laws, this site does not claim to be an online pharmacy operating in the US, does not make any medical claims to any US Citizens and does not advertise or offer to sell any drugs to them for their personal consumption or treatment. Buyers from the US can order for the products only if they require it for any scholarly study / Research / Test or Analysis uses only. The owner of this site and of the products and services referred to on this site only provides a service where consumers can obtain and compare information about various products. The owner has no monetary stake in the product and services advertised on the site. The owner agrees to receive payment at the Free Will of the consumer for release to the Pharmacy on proof of shipment and this is the extent of their monetary connection.
*** We make Express Shipments to all these Countries:...
Afghanistan, Albania, Algeria, American Samoa, Andorra, Angola, Anguilla, Antigua, Argentina, Armenia, Aruba, Australia, Austria, Azerbaijan, Bahamas, Bahrain, Bangladesh, Barbados, Belarus, Belgium, Belize, Benin, Bermuda, Bhutan, Bolivia, Bonaire, Bosnia and Herzegovina, Botswana, Brazil, Brunei, Bulgaria, Burkina Faso, Cambodia, Cameroon, Canary Islands, Cape Verde, Cayman Islands, Chad, Chile, China, Colombia, Comoros, Congo, Cook Islands, Costa Rica, Croatia, Curacao, Cyprus, Czech Republic, Denmark, Djibouti, Dominica, Dominican Republic, East Timor, Ecuador, Egypt, El Salvador, Estonia, Ethiopia, Falkland Islands, Faroe Islands, Fiji, Finland, France, French Guyana, Gabon, Gambia, Georgia, Germany, Ghana, Gibraltar, Greece, Greenland, Grenada, Guadeloupe, Guam, Guatemala, Guernsey, Guinea Republic, Guinea-Bissau, Guinea-Equatorial, Guyana (British), Haiti, Honduras, Hong Kong, Hungary, Iceland, Indonesia, Ireland, Israel, Italy, Jamaica, Japan, Jersey, Jordan, Kazakhstan, Kenya, Kiribati, South Korea, Kosovo, Kuwait, Kyrgyzstan, Laos, Latvia, Lebanon, Lesotho, Liechtenstein, Lithuania, Luxembourg, Macau, Macedonia, Madagascar, Malawi, Malaysia, Maldives, Malta, Marshall Islands, Martinique, Mauritania, Mauritius, Mayotte, Mexico, Micronesia, Moldova, Monaco, Mongolia, Montenegro, Montserrat, Morocco, Mozambique, Myanmar, Namibia, Nauru, Nepal, Netherlands, Nevis, New Caledonia, New Zealand, Nicaragua, Nigeria, Niue, Norway, Oman, Palau, Panama, Papua New Guinea, Paraguay, Peru, Philippines, Poland, Portugal, Puerto Rico, Qatar, Reunion Island, Romania, Russian Federation, Rwanda, Saint Helena, Samoa, San Marino, Sao Tome and Principe, Saudi Arabia, Senegal, Serbia, Seychelles, Sierra Leone, Singapore, Slovakia, Slovenia, Solomon Islands, Somaliland (North Somalia), South Africa, Spain, Sri Lanka, St. Barthelemy, St. Eustatius, St. Kitts, St. Lucia, St. Maarten, St. Vincent, Suriname, Swaziland, Sweden, Switzerland, Tahiti, Taiwan, Tajikistan, Tanzania, Thailand, Togo, Tonga, Trinidad and Tobago, Tunisia, Turkey, Turks and Caicos Islands, Tuvalu, Uganda, Ukraine, UAE, UK, USA, Uruguay, Uzbekistan, Vanuatu, Vatican City State, Venezuela, Vietnam, Virgin Islands (British), Virgin Islands (US), Zambia, Zimbabwe,
Buyer / Patient Reviews on buying
4.1 out of 5 stars
Generic ADO-TRASTUZUMAB EMTANSINE / Brand KADCYLA 100mg / 160mg Vial is used for treating cancer of the breast. Ado-Trastuzumab emtansine / Kadcyla medication is found effective in treating few types of cancer in the breast (human epidermal growth factor receptor 2- HER-2) and have expanded to other organs and failed to show any positive response to other anticancer medicines. Ado-Trastuzumab emtansine / Kadcyla medicine is classified as an anti-cancer medication that binds to HER2 receptors on cancer bearing cells of the breast and flags the cancer bearing cells for destruction by the immune system of the body. Ado-Trastuzumab emtansine / Kadcyla drug also sets into the cancer bearing cells to discharge a medicine of chemotherapy named Emtansine and prevents them from expanding and dividing.
Patient Package Inserts (PPI), Medication Guides (MG), and Instructions for Use (IFU) are paper handouts that come with many prescription medicines. The guides address issues that are specific to particular drugs and drug classes, and they contain FDA-approved information that can help patients use the medicine safe and effectively and try to avoid serious adverse events. Not all medicines have patient information and if you have questions about your medicines you should always talk with your Healthcare Provider or Pharmacist.
Medication Guides are developed by the manufacturer, approved by the FDA, and required to be given to consumers each time the medication is dispensed. You may see a printable pdf copy of the Medication Guide / Patient Information Leaflet of Kadcyla - Ado-Trastuzumab emtansine in English Arabic Bulgarian Chinese Dutch Filipino French Hebrew Japanese Korean Portuguese Romanian Russian Spanish Swedish Thai Turkish Vietnamese